Your session is about to expire
← Back to Search
Bone Hemostat
Experimental: Montage Bone Hemostat for Spinal Fusion
N/A
Waitlist Available
Led By William Lavelle, MD
Research Sponsored by Abyrx, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-year and 2-years post surgery
Awards & highlights
Study Summary
This trial looks at whether using MONTAGE Settable Resorbable Hemostatic Bone Putty during surgery reduces postoperative bleeding compared to not using it.
Eligible Conditions
- Spinal Fusion
- Ankylosing Spondylitis
- Scoliosis
- Kyphosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-year and 2-years post surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-year and 2-years post surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hemostasis
Secondary outcome measures
PSO Stability
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Montage Bone HemostatExperimental Treatment1 Intervention
Use of Montage Settable Resorbable Hemostatic bone putty on the cut surfaces of bleeding bone at the osteotomy site
Group II: Standard of Care: No bone hemostatActive Control1 Intervention
Use of no bone hemostat on the cut surfaces of bleeding bone at the osteotomy site
Find a Location
Who is running the clinical trial?
Abyrx, Inc.Lead Sponsor
1 Previous Clinical Trials
65 Total Patients Enrolled
William Lavelle, MDPrincipal InvestigatorSUNY Upstate
1 Previous Clinical Trials
200 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger